| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
John Heinrich last filed a Form 4 in May 2024, as Director at SRTS. John Heinrich's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns John Heinrich a middling insider score of 62/100, based on 3 past trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +44.6%.
At the last filing, the largest reported position was 59,940 shares of SRTS.
John Heinrich has 5 Form 4 filings on record from June 2016 to May 2024, all as Director at Sensus Healthcare (SRTS), 2016–2024.
The 7 reported transactions were 3 open-market purchases, 2 open-market sales and 2 stock awards.
Counted by filing, the open-market trades come to 2 purchases worth about $81K and 1 sale worth about $123K.
The largest open-market purchase was 10,000 shares of SRTS at an average $5.25 on June 3, 2016, about $53K.
The only open-market sale was 20,000 shares of SRTS at an average $6.17 on May 20, 2024, about $123K. Twelve months later SRTS was down 23%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | SRTS Sensus Healthcare, Inc. | Director | Sell | 20,000 | $6.17 | $123,415.83 | -25.0% | +12.6% | -23.3% | |
| May 11, 2023 | SRTS Sensus Healthcare, Inc. | Director | Buy | 10,000 | $2.86 | $28,600.00 | +14.3% | +32.3% | +85.6% | |
| Jun 3, 2016 | SRTS Sensus Healthcare, Inc. | Director | Buy | 10,000 | $5.25 | $52,500.00 | +33.4% | - | - |